Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia
Clinical trial NCT05079230 · TERMINATED
Trial details
- NCT number
- NCT05079230
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2024-04-11
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.